MR Imaging characteristics of patients with pathologic rRCCs
| Patient | Max Dimension (mm) | Bone Marrow Enhancement | T2 Signal | T2 Dark Nodule | T1 Hyperintense Signal | Location |
|---|---|---|---|---|---|---|
| 1 | 11.5 | Focal | Hyperintense | No | No | Midline |
| 2 | 14.0 | Focal | Hypointense | No | Yes | Midline |
| 3 | 10.8 | Diffuse | Heterogeneous | No | No | Midline |
| 4 | 10.8 | Diffuse | Hyperintense | Yes | Yes | Off-midline |
| 5 | 11.1 | Diffuse | Hyperintense | Yes | No | Midline |
| 6 | 8.2 | Focal | Heterogeneous | No | No | Replaces entire pituitary |
| 7 | 12.2 | Diffuse | Hyperintense | Yes | No | Replaces entire pituitary |
Note:—Max indicates maximum.